Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISPERIDONE Cause Therapeutic product effect variable? 143 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Therapeutic product effect variable have been filed in association with RISPERIDONE (Risperidone). This represents 0.2% of all adverse event reports for RISPERIDONE.

143
Reports of Therapeutic product effect variable with RISPERIDONE
0.2%
of all RISPERIDONE reports
0
Deaths
142
Hospitalizations

How Dangerous Is Therapeutic product effect variable From RISPERIDONE?

Of the 143 reports, 142 (99.3%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Therapeutic product effect variable Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 143 reports have been filed with the FAERS database.

What Other Side Effects Does RISPERIDONE Cause?

Gynaecomastia (24,453) Off label use (10,376) Abnormal weight gain (9,418) Weight increased (6,885) Emotional disorder (5,809) Product use in unapproved indication (5,551) Drug ineffective (5,232) Injury (4,447) Hyperprolactinaemia (4,124) Galactorrhoea (3,513)

What Other Drugs Cause Therapeutic product effect variable?

CARBIDOPA\LEVODOPA (316) LEVODOPA (298) RIMEGEPANT (177) GABAPENTIN (166) CLOZAPINE (157) DICLOFENAC (153) OLANZAPINE (150) FLUOXETINE (149) ARIPIPRAZOLE (148) AMISULPRIDE (147)

Which RISPERIDONE Alternatives Have Lower Therapeutic product effect variable Risk?

RISPERIDONE vs RITALIN RISPERIDONE vs RITLECITINIB RISPERIDONE vs RITODRINE RISPERIDONE vs RITONAVIR RISPERIDONE vs RITUXAN

Related Pages

RISPERIDONE Full Profile All Therapeutic product effect variable Reports All Drugs Causing Therapeutic product effect variable RISPERIDONE Demographics